Vor Biopharma

VOR53

Penny Stock

$0.86arrow_drop_down3.82%-$0.03

Penny Stock

VOR53

$0.86

arrow_drop_down3.82%-$0.03

Penny Stock

Performance History

Key Stats
Open	$0.93
Prev. Close	$0.89
EPS	-1.64
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$59.34M
PE Ratio	-

	LOW	HIGH
Day Range	0.84	0.94
52 Week Range	0.63	3.14

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-1.64

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Vor Biopharma (VOR)

Vor Biopharma Inc. (VOR) is a biopharmaceutical company that focuses on developing therapies for the treatment of blood cancers. The company leverages its expertise in oncology and antibody engineering to develop innovative treatments that target specific cancer cells. Vor Biopharma is dedicated to improving the lives of patients by providing them with personalized therapies that have the potential to be more effective and less toxic than traditional treatments.

Vor Biopharma's stock price history has shown significant growth over the past year. The company's shares have experienced steady growth, reflecting the market's positive response to its innovative therapies. Investors have recognized the potential of Vor Biopharma's pipeline and its ability to address critical unmet needs in the field of oncology.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Robert Ang M.B.A., M.D., MBBS
Headquarters: Cambridge
Employees: 133
Exchange: NASDAQ

Keep an eye on Vor Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Vor Biopharma's (VOR) price per share?

The current price per share for Vor Biopharma (VOR) is $0.86. The stock has seen a price change of -$0.03 recently, indicating a -3.82% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Vor Biopharma (VOR)?

For Vor Biopharma (VOR), the 52-week high is $3.14, which is 263.47% from the current price. The 52-week low is $0.63, the current price is 37.13% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Vor Biopharma (VOR) a growth stock?

Vor Biopharma (VOR) has shown an average price growth of -4.94% over the past three years. It has received a score of -1 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Vor Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Vor Biopharma (VOR) stock price performance year to date (YTD)?

As of the latest data, Vor Biopharma (VOR) has a year-to-date price change of -61.26%. Over the past month, the stock has experienced a price change of 30.01%. Over the last three months, the change has been 4.72%. Over the past six months, the figure is -48.58%.

help

Is Vor Biopharma (VOR) a profitable company?

Vor Biopharma (VOR) has a net income of -$117.86M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$126.04M. Furthermore, the EBITDA is -$121.2M.

help

What is the market capitalization of Vor Biopharma (VOR)?

Vor Biopharma (VOR) has a market capitalization of $59.09M. The average daily trading volume is 0.87, indicating the stock's liquidity and investor engagement.